Can brain cells rescue each other? The surprising role of mitochondrial delivery in Alzheimer’s research

By Alicia Fitzgerald

According to the WHO, in 2024 it was estimated that 50 million people worldwide were living with neurodegenerative diseases, a figure that is expected to rise. When learning about diseases such as Alzheimer’s, we are told that they’re progressive, which often implies that the brain simply succumbs to the disease. But what if that’s not the whole story and cells within the brain start actively helping each other to fight for survival? 

A paper published by Nature Neuroscience suggests exactly this. Scientists investigating Alzheimer’s-associated tau pathology in mice discovered a protective interaction between two types of glial brain cells: microglia and astrocytes. These cells are not neurons, but they play pivotal roles in maintaining the environment of neuronal cells.

Within cells, mitochondrial functioning is essential to cellular metabolism and generates much of the energy required for survival. When under Alzheimer’s associated tau pathology, astrocytes can lose mitochondrial function and enter a state of reactive astrogliosis, potentially disrupting their ability to support neurons. For Alzheimer’s, this exacerbates disease progression. However the brain has a clever mechanism to counteract the metabolic stress. Microglial cells can communicate with the astrocytes and actually send over functional mitochondria, rescuing them from their state of cellular stress and reducing harmful cellular responses.

Microglial cells contain a protein called GPNMB which was shown to be indispensable in the protective mechanism involving intercellular communication and transferral of mitochondria. In response to an abnormal tau – a protein associated with Alzheimer’s disease – GPNMB forms a complex on the mitochondria with a cleaved part of this tau protein and two mitophagy receptors. This results in the GPNMB and bioactive, functional mitochondria being packaged into extracellular vesicles (EV’s) and then released from the microglia to be taken up by the astrocytes. This restores functional mitochondrial respiration and ATP production, and suppresses pathways associated with astrogliosis.

To investigate whether this process could prevent cognitive decline, the researchers genetically modified mice with tau pathology to prevent GPNMB production in the microglia. Without this protein, the mitochondrial transfer across cells was disrupted and the mice exhibited more cognitive impairments. In contrast, mice with tau pathology that were treated with GPNMB-enriched EV’s, showed improvements in cognitive function. These findings suggest that mitochondrial transfer may be an important protective mechanism for a damaged brain.

These findings suggest that mitochondrial transfer may be an important protective mechanism for a damaged brain

These findings pose an idea that the brain might already possess all the mechanisms to protect itself against diseases such as Alzheimer’s. There is an enormous amount of research into drug therapeutics for neurodegenerative diseases, but perhaps scientists are missing what’s right under their nose. By taking a more introspective approach, scientists might be able to find a way to enhance the brain’s natural protective mechanisms. 

Although this paper has only shown these findings in preclinical research, and the exact mechanisms of Alzheimer’s are yet to be elucidated, it offers hope for the future of research. For a disease that affects such fundamental parts of human life: memories, independence, relationships and eventually all aspects of the brain and body’s function, there is a distinct and urgent need for a solution. Could this be a way forward for Alzheimer’s therapeutics?

Image: Goleisreintl via Wikimedia Commons